IF=10.8997,Journal for Immunotherapy of Cancer,復旦大學附屬中山醫院,慢病毒;質粒;siRNA.
ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3